Intravenous Artesunate and Malaria

• Status: Unknown status
• Trial end date: 2013-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Intravenous artesunate is egual to quinine in the treatment of severe malaria

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Khartoum
• Collaborators: Kassala; Sudan; University of Kassala, Sudan
• Treatments: Artemisinins; Artesunate; Quinine

Criteria

Inclusion Criteria:

severe P.falciparum malaria-

Exclusion Criteria:

mixed infection Pregnant women -